New study tests if All-Keyhole surgery beats hybrid approach for esophageal cancer
NCT ID NCT07408999
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 3 trial will compare two surgical techniques for esophageal cancer: totally minimally invasive esophagectomy (TMIE) using only keyhole incisions, versus a hybrid approach that combines keyhole and open chest surgery. The study aims to see if TMIE reduces severe complications after surgery. About 327 adults with resectable esophageal or gastroesophageal junction cancer will take part across multiple centers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Totally Minimally Invasive Esophagectomy (TMIE) - a surgical procedure using thoracoscopy instead of open chest surgery
What this could lead to
If TMIE proves better, it could become the new standard surgical approach for esophageal cancer, leading to fewer severe complications and faster recovery.
What could go wrong
This is a surgical technique comparison, not a new drug or cure. The trial is not yet recruiting, and results may show no significant difference between the two approaches.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Lille
Lille, 59037, France
Contact Phone: •••-•••-•••• Email: •••••@•••••